Rennova Health, Inc. (RNVA)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Sep 3, 2026, 4:00 PM EST
Rennova Health Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Cash & Equivalents | 0.05 | 0.5 | 0.72 | 0.03 | 0.02 |
Cash & Short-Term Investments | 0.05 | 0.5 | 0.72 | 0.03 | 0.02 |
Cash Growth | -90.19% | -31.06% | 2757.74% | 49.73% | 146.48% |
Accounts Receivable | 3.09 | 3.11 | 2.08 | 0.5 | 3.57 |
Other Receivables | 0.84 | 0.84 | 1.14 | 1.42 | 0.64 |
Receivables | 6.65 | 5.41 | 3.59 | 1.92 | 4.21 |
Inventory | 0.2 | 0.24 | 0.28 | 0.45 | 0.61 |
Prepaid Expenses | 0.04 | 0.22 | 0.12 | 0.15 | 0 |
Other Current Assets | - | - | - | 0.18 | 0.51 |
Total Current Assets | 6.94 | 6.36 | 4.72 | 2.72 | 5.35 |
Property, Plant & Equipment | 4.68 | 4.77 | 5.45 | 8.81 | 8.32 |
Long-Term Investments | 8.19 | 9.02 | 9.02 | - | - |
Other Intangible Assets | 0.26 | 0.26 | 0.26 | 0.26 | 0.51 |
Other Long-Term Assets | 0.18 | 0.17 | 0.19 | 0.46 | 0.53 |
Total Assets | 20.25 | 20.57 | 19.63 | 12.26 | 14.71 |
Liabilities
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Accounts Payable | 12.37 | 11.2 | 12.14 | 14.25 | 12.81 |
Accrued Expenses | 15.25 | 18.83 | 12.34 | 12.24 | 14.25 |
Short-Term Debt | 3.19 | 5.62 | 5.73 | 3.66 | 17.06 |
Current Portion of Long-Term Debt | - | 8.91 | 9.29 | 15.92 | 31.95 |
Current Portion of Leases | 0.18 | 0.22 | 0.47 | 0.42 | 1.15 |
Current Income Taxes Payable | 1.59 | 1.35 | 1.34 | 1.44 | 1.37 |
Other Current Liabilities | 9.91 | 3.17 | 5.07 | 11.25 | 4.83 |
Total Current Liabilities | 42.51 | 49.31 | 46.36 | 59.18 | 83.42 |
Long-Term Debt | 8.22 | - | - | 1.2 | - |
Long-Term Leases | 0.18 | 0.36 | 0.57 | 0.83 | 0.06 |
Other Long-Term Liabilities | 6.19 | - | - | 0.08 | 0.1 |
Total Liabilities | 57.1 | 49.67 | 46.94 | 61.28 | 83.58 |
Shareholders' Equity
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Common Stock | 4.06 | 2.91 | 0 | - | 0 |
Additional Paid-In Capital | 1,670 | 1,672 | 1,342 | 819.5 | 510.4 |
Retained Earnings | -1,711 | -1,704 | -1,369 | -868.54 | -586.94 |
Total Common Equity | -36.83 | -29.1 | -27.32 | -49.04 | -76.54 |
Minority Interest | -0.02 | - | - | - | - |
Shareholders' Equity | -36.84 | -29.09 | -27.3 | -49.02 | -68.87 |
Total Liabilities & Equity | 20.25 | 20.57 | 19.63 | 12.26 | 14.71 |
Additional Metrics
Fiscal Year | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
Period Ending | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
Total Debt | 11.78 | 15.11 | 16.06 | 22.02 | 50.22 |
Net Cash (Debt) | -11.73 | -14.61 | -15.33 | -22 | -50.2 |
Net Cash Growth | - | - | - | - | - |
Net Cash Per Share | -0.00 | -0.00 | -27.96 | - | - |
Filing Date Shares Outstanding | 43,051 | 29,934 | 36.25 | - | - |
Total Common Shares Outstanding | 40,551 | 29,084 | 4.24 | - | - |
Working Capital | -35.56 | -42.94 | -41.64 | -56.45 | -78.07 |
Book Value Per Share | -0.00 | -0.00 | -6.44 | - | - |
Tangible Book Value | -37.09 | -29.36 | -27.58 | -49.3 | -77.05 |
Tangible Book Value Per Share | -0.00 | -0.00 | -6.50 | - | - |
Land | 0.55 | 0.55 | 0.55 | 0.55 | 0.57 |
Buildings | 4.27 | 4.18 | 4.18 | 6.48 | 6.55 |
Machinery | 1.9 | 1.71 | 3 | 3.69 | 3.32 |
Leasehold Improvements | 0.15 | 0 | 0 | 0.09 | 0.08 |